Clinical Trial Update: PRACTECAL-PKPD Sub Study [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update for the PRACTECAL-PKPD Sub Study investigating treatment regimens for drug-resistant tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensively Drug-resistant Tuberculosis
• Multidrug-resistant Tuberculosis
• Pulmonary Tuberculosis

Snippet

Sponsor: Medecins Sans Frontieres, Netherlands | Conditions: Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis | Phase 2, Phase 3 | Status: UNKNOWN